Skip to main content

Recall one batch of Dextrose Injection 5% USP (Baxter) 1000ml(HK-41323)

  • 2015.03.12

The Department of Health (DH) today (March 12) endorsed a licensed drug wholesaler, Baxter Healthcare Limited (Baxter), to conduct a voluntary recall of one batch (batch number: C926899) of Dextrose Injection 5% USP (Baxter) 1000ml (HK-41323) from the market due to potential quality issue.

DH received notification from Baxter today that the US manufacturer of the product has received complaints for missing closure and/or leaks in some packs of the affected batch of the product. Since missing closure and/or leaks in the product may place patients at an increased risk of infection, the US manufacturer decided to recall the affected batch as a precautionary measure. The DH has requested Baxter to provide a detailed investigation report as soon as possible.

Dextrose Injection 5% USP (Baxter) containing dextrose is a solution for fluid replenishment and caloric supply for intravenous administration. According to Baxter, 476 packs of the affected batch have been supplied to private and HA hospitals. So far, the DH has not received any adverse reports in connection with the product.

The DH's investigation is continuing.

Baxter has set up hotline (6113 9236) to answer related enquiries. The DH will closely monitor the recall.